These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7343602)

  • 1. Complement fixing antigen in rabies. VII. Its application in sero-survey of vaccinated subjects.
    Rai Chowdhuri AN; Bhardwaj M; Sivaraman CA
    J Commun Dis; 1981 Sep; 13(3):172-80. PubMed ID: 7343602
    [No Abstract]   [Full Text] [Related]  

  • 2. [Complement-fixing rabies antibodies in mice vaccinated and posteriorly challenged].
    Oliveira LH; Andrade CM; Reis W
    An Microbiol (Rio J); 1980; 25():135-47. PubMed ID: 6982627
    [No Abstract]   [Full Text] [Related]  

  • 3. [The complement-fixation test in rabies. I. Antibody titer of vaccinated dogs (author's transl)].
    Nilsson TT; Pinto AA; Nilsson MR
    Arq Inst Biol (Sao Paulo); 1975; 42():197-202. PubMed ID: 1236050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell mediated immune response in canine antirabies vaccination.
    Timenetsky J; Chamelet EL; Mendes NF; Pereira OA
    Rev Inst Med Trop Sao Paulo; 1985; 27(1):1-5. PubMed ID: 4035202
    [No Abstract]   [Full Text] [Related]  

  • 5. Development and evaluation of a competitive ELISA for estimation of rabies neutralizing antibodies after post-exposure rabies vaccination in humans.
    Muhamuda K; Madhusudana SN; Ravi V
    Int J Infect Dis; 2007 Sep; 11(5):441-5. PubMed ID: 17321182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement fixing antigens in rabies. VI. Correlation of complement fixing and neutralizing antibodies.
    Rai Chowdhuri AN; Bhardwaj M; Sivaraman CA
    J Commun Dis; 1980 Dec; 12(4):197-200. PubMed ID: 7320482
    [No Abstract]   [Full Text] [Related]  

  • 7. Survival of neutralizing antibody in previously rabies vaccinated subjects: a prospective study showing long lasting immunity.
    Suwansrinon K; Wilde H; Benjavongkulchai M; Banjongkasaena U; Lertjarutorn S; Boonchang S; Suttisri R; Khowplod P; Daviratanasilpa S; Sitprija V
    Vaccine; 2006 May; 24(18):3878-80. PubMed ID: 16530893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Investigation of antibody levels following rabies vaccination in the subjects who were biten by animals].
    Baysal B; Tosun S; Ozdemir M; Doğan M
    Mikrobiyol Bul; 2009 Jan; 43(1):127-31. PubMed ID: 19334389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duration of immunity: an anamnestic response 14 years after rabies vaccination with purified chick embryo cell rabies vaccine.
    Malerczyk C; Briggs DJ; Dreesen DW; Banzhoff A
    J Travel Med; 2007; 14(1):63-4. PubMed ID: 17241256
    [No Abstract]   [Full Text] [Related]  

  • 10. Factors influencing the antibody response of dogs vaccinated against rabies.
    Kennedy LJ; Lunt M; Barnes A; McElhinney L; Fooks AR; Baxter DN; Ollier WE
    Vaccine; 2007 Dec; 25(51):8500-7. PubMed ID: 18006120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Quantification of complement-fixing rabies antibodies and of IgM and IgG type immunoglobulins in vaccinated white Swiss mice].
    Oliveira LH; Andrade Cde M; Reis W
    An Microbiol (Rio J); 1979; 24():37-43. PubMed ID: 318089
    [No Abstract]   [Full Text] [Related]  

  • 12. A pilot study on intradermal vaccination of Japanese rabies vaccine for pre-exposure immunization.
    Shiota S; Khawplod P; Ahmed K; Mifune K; Nishizono A
    Vaccine; 2008 Nov; 26(50):6441-4. PubMed ID: 18804510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressant effect of human or equine rabies immunoglobulins on the immunogenicity of post-exposure rabies vaccination under the 2-1-1 regimen: a field trial in Indonesia. MAS054 Clinical Investigator Group.
    Lang J; Simanjuntak GH; Soerjosembodo S; Koesharyono C
    Bull World Health Organ; 1998; 76(5):491-5. PubMed ID: 9868840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of homologous vs. heterologous challenge virus strains on the serological test results of rabies virus neutralizing assays.
    Moore SM; Ricke TA; Davis RD; Briggs DJ
    Biologicals; 2005 Dec; 33(4):269-76. PubMed ID: 16168666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of antibody responses after vaccination with two inactivated rabies vaccines.
    Minke JM; Bouvet J; Cliquet F; Wasniewski M; Guiot AL; Lemaitre L; Cariou C; Cozette V; Vergne L; Guigal PM
    Vet Microbiol; 2009 Jan; 133(3):283-6. PubMed ID: 18757142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of rabies virus complement-fixing antibodies in unvaccinated dogs, humans and livestock in Anambra State of Nigeria.
    Iroegbu CU; Uhuegbu E
    Microbiologica; 1992 Apr; 15(2):213-7. PubMed ID: 1602992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immunogenicity study of a newly introduced purified Vero cell rabies vaccine (Abhayrab) manufactured in India.
    Sampath G; Reddy SV; Rao ML; Rao YU; Palaniappan C
    Vaccine; 2005 Jan; 23(7):897-900. PubMed ID: 15603890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified Thai Red Cross regimen.
    Madhusudana SN; Sanjay TV; Mahendra BJ; Suja MS
    Int J Infect Dis; 2004 May; 8(3):175-9. PubMed ID: 15109593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rabies DNA vaccination by the intranasal route in dogs.
    Tesoro Cruz E; Hernández González R; Alonso Morales R; Aguilar-Setién A
    Dev Biol (Basel); 2006; 125():221-31. PubMed ID: 16878480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular and humoral immune response in human beings vaccinated with rabies vaccine.
    Ramanna BC; Pal SR
    J Commun Dis; 1980 Sep; 12(3):139-43. PubMed ID: 7229310
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.